Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017;30(1):101-105.
doi: 10.20524/aog.2016.0097. Epub 2016 Oct 20.

Viral hepatitis status does not affect survival in patients with hepatocellular carcinoma

Eyas Alkhalili  1 , Alissa Greenbaum  1 , Li Luo  1 , Rodrigo Rodriguez  1 , Katharine Caldwell  1 , Oscar Munoz Estrada  1 , Jacqueline O'Neill  1 , Itzhak Nir  1 , Katherine T Morris  1
Affiliations

Viral hepatitis status does not affect survival in patients with hepatocellular carcinoma

Eyas Alkhalili et al. Ann Gastroenterol. 2017.

Abstract

Background: There have been few studies on the impact of viral etiology on the prognosis in patients with hepatocellular carcinoma (HCC). The aim of this study was to evaluate the clinical characteristics and survival of patients with viral hepatitis-associated HCC (V-HCC), compared to patients with HCC of non-hepatitis B, non-hepatitis C (NBNC-HCC) etiology.

Methods: We performed a retrospective analysis of all patients with HCC treated at our comprehensive cancer center from 2000 through 2014. Patients were divided into two groups according to their viral hepatitis status. Presentation patterns, treatments, and survival data were analyzed.

Results: We evaluated 366 patients: 233 patients (63.7%) had V-HCC while 133 (36.3%) patients had NBNC-HCC. V-HCC patients were younger (P<0.0001) and more likely to be male (P=0.001). Decompensated cirrhosis was more prevalent in V-HCC patients (P=0.01). There was no difference in the resectability rate or disease stage. In patients with resectable disease, those with V-HCC were less likely to undergo hepatectomy (23.7% vs. 38%; P=0.04) for more advanced liver disease. The estimated median survival for V-HCC was 13 months compared to 16 months in NBNC-HCC patients (P=0.57). On multivariate analysis, disease stage (P<0.0001) and Child-Pugh class (P<0.0001) were independent factors affecting survival, but viral status was not (P=0.75).

Conclusion: Despite presenting with more advanced cirrhosis and being less likely to undergo surgery, V-HCC patients had similar survival to patients with NBNC-HCC.

Keywords: Hepatocellular carcinoma; survival; viral hepatitis.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
Kaplan-Meier overall survival curves by viral status
Figure 2
Figure 2
Stage-specific Kaplan-Meier survival curves by viral status
See this image and copyright information in PMC

References

    1. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264–1273. e1. - PMC - PubMed
    1. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003;139:817–823. - PubMed
    1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576. - PubMed
    1. Poon D, Anderson BO, Chen LT, et al. Asian Oncology Summit. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009;10:1111–1118. - PubMed
    1. Gurtsevitch VE. Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Biochemistry (Mosc) 2008;73:504–513. - PubMed

LinkOut - more resources